Other OTC - Delayed Quote • USD
Biostar Pharmaceuticals, Inc. (BSPM)
At close: December 27 at 3:20 PM EST
Breakdown
TTM
Total Revenue
317.7940
Cost of Revenue
354.5410
Gross Profit
-36.7470
Operating Expense
-2,822.0890
Operating Income
2,785.3420
Net Non Operating Interest Income Expense
-198.8240
Other Income Expense
1,000.8890
Pretax Income
3,587.4070
Tax Provision
2,653.0540
Net Income Common Stockholders
934.3530
Diluted NI Available to Com Stockholders
934.3530
Basic EPS
0.68
Diluted EPS
0.68
Basic Average Shares
2,617.0420
Diluted Average Shares
2,617.0420
Total Operating Income as Reported
2,785.3420
Total Expenses
-2,467.5480
Net Income from Continuing & Discontinued Operation
934.3530
Normalized Income
581.8995
Interest Income
2.4860
Interest Expense
201.3100
Net Interest Income
-198.8240
EBIT
3,788.7170
EBITDA
4,897.7060
Reconciled Cost of Revenue
354.5410
Reconciled Depreciation
1,108.9890
Net Income from Continuing Operation Net Minority Interest
934.3530
Total Unusual Items Excluding Goodwill
469.9380
Total Unusual Items
469.9380
Normalized EBITDA
4,427.7680
Tax Rate for Calcs
0.0003
Tax Effect of Unusual Items
117.4845
-
Yahoo Finance Plus Essential access required. Unlock Access